Ranjini K Sundaram

7PUBLICATIONS
71CO-AUTHORS
Gene and molecular therapyHaematological tumoursCellular nervous systemMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 29, 2026
Targeting O6-methylguanine-DNA Methyltransferase Deficiency in Preclinical Models of Extracranial Human Cancers with a Tumor-Selective DNA-Modifying Agent.

|Jul 17, 2026
Leveraging Homologous Recombination Deficiency via the Repositioned Prodrug CB1954.

|Apr 22, 2026
NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition.

|Jul 01, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion.

Katelyn J Noronha, Karlie N Lucas, Sateja Paradkar

|May 01, 2024
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors.

Matthew A Murray, Katelyn J Noronha, Yazhe Wang

|Jul 28, 2022
Mechanism-based design of agents that selectively target drug-resistant glioma.

Kingson Lin, Susan E Gueble, Ranjini K Sundaram

Pageof 2

Frequent Collaborators

6 joint publications

Ranjit S Bindra

4 joint publications

Juan C Vasquez

3 joint publications

Karlie N Lucas

3 joint publications

Katelyn J Noronha